Literature DB >> 12473269

Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome.

Deborah P M Symmons1.   

Abstract

Rheumatoid arthritis (RA) is the most common chronic inflammatory joint disease. There is some evidence that it may have been brought from North America to Europe during the 18th century. Its arrival in rural parts of the developing world is still more recent. The incidence and prevalence of RA appear to have fallen in Europe, North America and Japan in the last 50 years. During this time the peak age of onset has risen. Risk factors for the development of RA include genetic factors, an adverse pregnancy outcome, smoking, obesity and recent infections. The oral contraceptive pill and some dietary constituents may be protective. Older age and female gender are risk factors both for the development of RA and for a worse outcome. This risk factor profile offers some opportunities for primary and secondary prevention. However, treatment is the greatest determinant of RA outcome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12473269     DOI: 10.1053/berh.2002.0257

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  82 in total

1.  Maintenance of immune tolerance to a neo-self acetylcholine receptor antigen with aging: implications for late-onset autoimmunity.

Authors:  Sue Stacy; Earlanda L Williams; Nathan E Standifer; Amanda Pasquali; Keith A Krolick; Anthony J Infante; Ellen Kraig
Journal:  J Immunol       Date:  2010-04-30       Impact factor: 5.422

Review 2.  Developing the next generation of monoclonal antibodies for the treatment of rheumatoid arthritis.

Authors:  Jamie Campbell; David Lowe; Matthew A Sleeman
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

3.  Genetic link of type 1 diabetes susceptibility loci with rheumatoid arthritis in Pakistani patients.

Authors:  Aysha Karim Kiani; Sidrah Jahangir; Sidrah Jahngir; Peter John; Attya Bhatti; Asima Zia; Xingbin Wang; F Yesim Demirci; M Ilyas Kamboh
Journal:  Immunogenetics       Date:  2015-04-24       Impact factor: 2.846

4.  Assessment of cognitive function in female rheumatoid arthritis patients: associations with cerebrovascular pathology, depression and anxiety.

Authors:  Csaba Oláh; Zsófia Kardos; Mónika Andrejkovics; Enikő Szarka; Katalin Hodosi; Andrea Domján; Mariann Sepsi; Attila Sas; László Kostyál; Katalin Fazekas; Ágnes Flórián; Katalin Lukács; Ágnes Miksi; Zsuzsanna Baráth; György Kerekes; Márta Péntek; Attila Valikovics; László Tamási; Dániel Bereczki; Zoltán Szekanecz
Journal:  Rheumatol Int       Date:  2019-09-25       Impact factor: 2.631

5.  Prevalence and correlates of inflammatory arthritis in Germany: data from the First National Health Survey.

Authors:  S Schneider; G Schmitt; W Richter
Journal:  Rheumatol Int       Date:  2006-07-04       Impact factor: 2.631

6.  The Clinical Use of Curcumin for the Treatment of Rheumatoid Arthritis: A Systematic Review of Clinical Trials.

Authors:  Mohammad Bagherniya; Mina Darand; Gholamreza Askari; Paul C Guest; Thozhukat Sathyapalan; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  A prospective approach to investigating the natural history of preclinical rheumatoid arthritis (RA) using first-degree relatives of probands with RA.

Authors:  Jason R Kolfenbach; Kevin D Deane; Lezlie A Derber; Colin O'Donnell; Michael H Weisman; Jane H Buckner; Vivian H Gersuk; Shan Wei; Ted R Mikuls; James O'Dell; Peter K Gregersen; Richard M Keating; Jill M Norris; V Michael Holers
Journal:  Arthritis Rheum       Date:  2009-12-15

8.  [Recommendations for tuberculosis screening before initiation of TNF-alpha-inhibitor treatment in rheumatic diseases].

Authors:  R Diel; B Hauer; R Loddenkemper; B Manger; K Krüger
Journal:  Z Rheumatol       Date:  2009-07       Impact factor: 1.372

Review 9.  Rheumatoid arthritis and metabolic syndrome.

Authors:  György Kerekes; Michael T Nurmohamed; Miguel A González-Gay; Ildikó Seres; György Paragh; Zsófia Kardos; Zsuzsa Baráth; László Tamási; Pál Soltész; Zoltán Szekanecz
Journal:  Nat Rev Rheumatol       Date:  2014-08-05       Impact factor: 20.543

10.  Abatacept: a T-cell co-stimulation modulator for the treatment of rheumatoid arthritis.

Authors:  Andrew J K Ostör
Journal:  Clin Rheumatol       Date:  2008-08-01       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.